Domov › Akutna limfoblastna levkemija › Texas › Houston
Klinične študije za Akutna limfoblastna levkemija v Houston, TX
28 študij za Akutna limfoblastna levkemija išče udeležence na lokacijah v Houston in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
Vključevanje udeležencevFaza 1
- Houston Methodist Hospital, Houston
- Texas Children's Hospital, Houston
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- UT MD Anderson Cancer Center, Houston
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Vključevanje udeležencevOpazovalna študija
- Texas Children's Hospital, Houston
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
Vključevanje udeležencevFaza 1
- University of Texas MD Anderson Cancer Center, Houston
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
Vključevanje udeležencevFaza 2
- MD Anderson Cancer Center, Houston
Evaluating the Relationship Between Skin Color and Pulse Oximeter Accuracy in Children
Vključevanje udeležencevOpazovalna študija
- Texas Children's Hospital, Houston
Phase I/II Study of the Combination of Blinatumomab and Asciminib in Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Vključevanje udeležencevFaza 1/2
- MD Anderson Cancer Center, Houston
First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.
Vključevanje udeležencevFaza 1
- Texas Children's Hospital, Houston
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Vključevanje udeležencevFaza 1/2
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
- UT MD Anderson Cancer Center, Houston
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
Vključevanje udeležencevFaza 2
- Baylor Texas Children's Hospital, Houston
A Study of CTD402 in T-ALL/LBL Patients
Vključevanje udeležencevFaza 1/2
- MD Anderson Cancer Center, Houston
Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment
Vključevanje udeležencevOpazovalna študija
- Baylor College of Medicine Houston, Houston
Phase 2 Study Assessing the Clinical Activity and Safety of Obecabtagene Autoleucel as a Consolidation in Patients With Newly Diagnosed High-risk B-cell Acute Lymphocytic Leukemia (ALL)
Vključevanje udeležencevFaza 2
- The University of Texas M. D. Anderson Cancer Center, Houston
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
Vključevanje udeležencevFaza 2
- M D Anderson Cancer Center, Houston
Personalized NK Cell Therapy in CBT
Vključevanje udeležencevFaza 2
- M D Anderson Cancer Center, Houston
Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
Vključevanje udeležencevFaza 1/2
- Research Site, Houston
Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
Vključevanje udeležencevFaza 1/2
- Research Site, Houston
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Vključevanje udeležencevOpazovalna študija
- M.D. Anderson Cancer Center, Houston
- Texas Children's Hospital - Baylor Medical Center, Houston
A Study of Revumenib and Mezigdomide in People With Leukemia
Vključevanje udeležencevFaza 1/2
- MD Anderson Cancer Center (Data Collection Only), Houston
TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
Vključevanje udeležencevFaza 1/2
- MD Anderson, Houston
Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic Leukemia
Vključevanje udeležencevFaza 2
- M D Anderson Cancer Center, Houston
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
Vključevanje udeležencevOpazovalna študija
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
Vključevanje udeležencevFaza 1
- MD Anderson Cancer Center, Houston
A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)
Vključevanje udeležencevFaza 3
- Ascentage Investigative Site #1501, Houston
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Vključevanje udeležencevFaza 1/2
- MDACC, Houston
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Vključevanje udeležencevFaza 2
- MD Anderson, Houston
Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL
Vključevanje udeležencevFaza 1
- University of Texas MD Anderson Cancer Center, Houston
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
Vključevanje udeležencevFaza 1
- Texas Children's Hospital/Baylor College of Medicine, Houston
Študije za Akutna limfoblastna levkemija v drugih mestih
- New York City, NY24 študij
- Baldwin Park, CA21 študij
- Seattle, WA21 študij
- Chicago, IL19 študij
- Atlanta, GA19 študij
- Philadelphia, PA16 študij
- Memphis, TN16 študij
- Washington, DC16 študij
- Boston, MA15 študij
- Los Angeles, CA14 študij
- Durham, NC13 študij
- Mountain View, CA13 študij
Druge študije v Houston
- Nemalicelični pljučni rak145 študij
- Rak dojke126 študij
- Rak (vse vrste)121 študij
- Metastatski rak104 študij
- Kolorektalni rak102 študij
- Rak jajčnikov89 študij
- Akutna mieločna levkemija85 študij
- Rak pljuč78 študij
- Rak prostate76 študij
- Rak endometrija68 študij
- Rak trebušne slinavke61 študij
- Melanom59 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.